You have 9 free searches left this month | for more free features.

Condition

Advanced Cancer (1)

Carcinoma, Renal Cell (1)

Metastatic Solid Tumor (1)

Solid Tumor (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

Bayer (1)

Tachyon Therapeutics, Inc. (1)

Collaborator

Amgen (1)

Intervention

placebo (1)

sorafenib (nexavar, bay43-9006) (1)

tach101 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

TACH101

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Cancer, Metastatic Solid Tumor, Solid Tumor Trial (TACH101)

Recruiting

Advanced Cancer
+2 more

TACH101

Austin, Texas

NEXT Oncology

Jan 25, 2023

Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed

Carcinoma, Renal Cell

Sorafenib (Nexavar, BAY43-9006)
Placebo

Tucson, Arizona
+120 more

Jan 8, 2014